Annual SGA
$5.71 M
-$1.42 M-19.93%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual SGA is $5.71 million, with the most recent change of -$1.42 million (-19.93%) on December 1, 2023.
- During the last 3 years, NRSN annual SGA has risen by +$5.32 million (+1353.94%).
- NRSN annual SGA is now -19.93% below its all-time high of $7.14 million, reached on December 31, 2022.
Performance
NRSN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$946.00 K
-$515.00 K-35.25%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly SGA is $946.00 thousand, with the most recent change of -$515.00 thousand (-35.25%) on September 1, 2024.
- Over the past year, NRSN quarterly SGA has dropped by -$166.00 thousand (-14.93%).
- NRSN quarterly SGA is now -54.84% below its all-time high of $2.10 million, reached on December 1, 2023.
Performance
NRSN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$130.50 M
-$5.41 M-4.33%
September 1, 2024
Summary
- As of February 10, 2025, NRSN TTM SGA is -$130.50 million, with the most recent change of -$5.41 million (-4.33%) on September 1, 2024.
- Over the past year, NRSN TTM SGA has dropped by -$136.19 million (-2394.76%).
- NRSN TTM SGA is now -2862.61% below its all-time high of -$4.41 million.
Performance
NRSN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NRSN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | -14.9% | -2394.8% |
| 3 y3 years | +1353.9% | -45.0% | -2410.6% |
| 5 y5 years | +1595.5% | +928.3% | -10000.0% |
NRSN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | +128.1% | -54.8% | at low | -720.6% | at low |
| 5 y | 5-year | -19.9% | +1595.5% | -54.8% | +928.3% | -2862.6% | at low |
| alltime | all time | -19.9% | +1595.5% | -54.8% | +928.3% | -2862.6% | at low |
NeuroSense Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $946.00 K(-35.2%) | $5.61 M(-2.1%) |
| Jun 2024 | - | $1.46 M(+31.4%) | $5.74 M(+0.9%) |
| Mar 2024 | - | $1.11 M(-46.9%) | $5.69 M(-0.5%) |
| Dec 2023 | $5.71 M(-19.9%) | $2.10 M(+96.2%) | $5.71 M(+4.8%) |
| Sep 2023 | - | $1.07 M(-24.4%) | $5.45 M(-9.1%) |
| Jun 2023 | - | $1.41 M(+24.0%) | $6.00 M(-4.9%) |
| Mar 2023 | - | $1.14 M(-37.9%) | $6.31 M(-11.6%) |
| Dec 2022 | $7.14 M | $1.83 M(+13.8%) | $7.14 M(+3.4%) |
| Sep 2022 | - | $1.61 M(-6.2%) | $6.90 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.72 M(-12.6%) | $5.65 M(+28.9%) |
| Mar 2022 | - | $1.97 M(+23.1%) | $4.38 M(+74.9%) |
| Dec 2021 | $2.50 M(+537.4%) | - | - |
| Dec 2021 | - | $1.60 M(+342.9%) | $2.50 M(+176.5%) |
| Sep 2021 | - | $361.00 K(-20.3%) | $906.00 K(+66.2%) |
| Jun 2021 | - | $453.00 K(+392.4%) | $545.00 K(+492.4%) |
| Mar 2021 | - | $92.00 K | $92.00 K |
| Dec 2020 | $393.00 K(+16.6%) | - | - |
| Dec 2019 | $337.00 K | - | - |
FAQ
- What is NeuroSense Therapeutics annual SGA?
- What is the all time high annual SGA for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual SGA year-on-year change?
- What is NeuroSense Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly SGA year-on-year change?
- What is NeuroSense Therapeutics TTM SGA?
- What is the all time high TTM SGA for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics TTM SGA year-on-year change?
What is NeuroSense Therapeutics annual SGA?
The current annual SGA of NRSN is $5.71 M
What is the all time high annual SGA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual SGA is $7.14 M
What is NeuroSense Therapeutics annual SGA year-on-year change?
Over the past year, NRSN annual SGA has changed by -$1.42 M (-19.93%)
What is NeuroSense Therapeutics quarterly SGA?
The current quarterly SGA of NRSN is $946.00 K
What is the all time high quarterly SGA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly SGA is $2.10 M
What is NeuroSense Therapeutics quarterly SGA year-on-year change?
Over the past year, NRSN quarterly SGA has changed by -$166.00 K (-14.93%)
What is NeuroSense Therapeutics TTM SGA?
The current TTM SGA of NRSN is -$130.50 M
What is the all time high TTM SGA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high TTM SGA is -$4.41 M
What is NeuroSense Therapeutics TTM SGA year-on-year change?
Over the past year, NRSN TTM SGA has changed by -$136.19 M (-2394.76%)